Загрузка...
Remodeling T cell compartments during anti-CD3 immunotherapy of type 1 diabetes
The immunological mechanism(s) of action whereby teplizumab preserves C-peptide levels in the progression of patients with recent onset type 1 diabetes (T1D) is still not well understood. In the present study, we evaluated the kinetics of T cell modulation in peripheral blood following two 14-day co...
Сохранить в:
| Опубликовано в: : | Cell Immunol |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5614459/ https://ncbi.nlm.nih.gov/pubmed/28844471 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cellimm.2017.07.007 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|